Covid-19, Adverse Scrutiny and The Journey to Code: where next for biometric tech?

Between leaving a Big Four accountancy firm on New Year's Eve and joining DWF Law as head of data protection and cyber-security, I spent a month developing a new business plan – fine-tuning a number of ideas I'd been working on concerning the future of data protection and privacy. This tim...

Descripción completa

Detalles Bibliográficos
Autor principal: Room, Stewart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250093/
http://dx.doi.org/10.1016/S0969-4765(20)30062-X
_version_ 1783538709714436096
author Room, Stewart
author_facet Room, Stewart
author_sort Room, Stewart
collection PubMed
description Between leaving a Big Four accountancy firm on New Year's Eve and joining DWF Law as head of data protection and cyber-security, I spent a month developing a new business plan – fine-tuning a number of ideas I'd been working on concerning the future of data protection and privacy. This time allowed me to confirm the business plan should focus on two core ideas: namely ‘Adverse Scrutiny’ and ‘The Journey to Code'.
format Online
Article
Text
id pubmed-7250093
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72500932020-05-27 Covid-19, Adverse Scrutiny and The Journey to Code: where next for biometric tech? Room, Stewart Biometric Technology Today Feature Between leaving a Big Four accountancy firm on New Year's Eve and joining DWF Law as head of data protection and cyber-security, I spent a month developing a new business plan – fine-tuning a number of ideas I'd been working on concerning the future of data protection and privacy. This time allowed me to confirm the business plan should focus on two core ideas: namely ‘Adverse Scrutiny’ and ‘The Journey to Code'. Elsevier Ltd. 2020-05 2020-05-26 /pmc/articles/PMC7250093/ http://dx.doi.org/10.1016/S0969-4765(20)30062-X Text en Copyright © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Feature
Room, Stewart
Covid-19, Adverse Scrutiny and The Journey to Code: where next for biometric tech?
title Covid-19, Adverse Scrutiny and The Journey to Code: where next for biometric tech?
title_full Covid-19, Adverse Scrutiny and The Journey to Code: where next for biometric tech?
title_fullStr Covid-19, Adverse Scrutiny and The Journey to Code: where next for biometric tech?
title_full_unstemmed Covid-19, Adverse Scrutiny and The Journey to Code: where next for biometric tech?
title_short Covid-19, Adverse Scrutiny and The Journey to Code: where next for biometric tech?
title_sort covid-19, adverse scrutiny and the journey to code: where next for biometric tech?
topic Feature
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250093/
http://dx.doi.org/10.1016/S0969-4765(20)30062-X
work_keys_str_mv AT roomstewart covid19adversescrutinyandthejourneytocodewherenextforbiometrictech

Ejemplares similares